Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline plus CBT for smoking cessation in adults with psychotic illness
ACTRN12609000270213Phase 4Not yet recruiting
- Sponsor
- Pfizer
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varenicline in nicotine dependence, sponsored by Pfizer. Primary endpoint: Smoking cessation. Planned start May 2009; status: not yet recruiting.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12609000270213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000270213.